ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C02KX04 | B | Macitentan - 10mg | 8898/388 | 140616/1 | OPSUMIT | 10mg | 30 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | L.L | 2.44 | E2 | Actelion Pharmaceuticals Ltd | Switzerland | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C02KX04 | B | Macitentan - 10mg | 8898 | 140616/1 | OPSUMIT | 10mg | 30 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | 201,006,231 L.L | 2.44 | E2 | Actelion Pharmaceuticals Ltd | Switzerland | 2/5/2024 | 0 |